Blog - INTERNET MÉDICA

■ Calidad de vida relacionada con la salud en adultos con síndrome de intestino irritable en un hospital de especialidades de México: estudio transversal.

Sánchez-Cuén, Jaime Alberto et al

Rev. esp. enferm. dig., Apr 2017, vol.109, no.4, p.265-272

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000400005&lng=en&nrm=iso&tlng=es

■ Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet?

Angela Rizzi, Eleonora Nucera, Lucrezia Laterza et al

J Neurogastroenterol Motil. 2017 Jan; 23(1): 101–108

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216640/

■ Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey

Martín Cañón, Alvaro J. Ruiz, Martín Rondón, Jaime Alvarado

Ann Gastroenterol. 2017; 30(1): 67–75

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198249/

■ Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study

Martin Aasbrenn, Ingvild Høgestøl, Inger Eribe et al

BMC Obes. 2017; 4: 22

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490229/

■ Systematic review: the placebo effect of psychological interventions in the treatment of irritable bowel syndrome

Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R van Rood, André J P M Smout, Niek J de Wit

World J Gastroenterol. 2017 Mar 28; 23(12): 2223–2233

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374135/

■ Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice

Susan Lucak, Lin Chang, Albena Halpert, Lucinda A. Harris

Therap Adv Gastroenterol. 2017 , vol 10(2): 253–275

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298476/

■ Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study

Chloé Melchior, Moutaz Aziz, Typhaine Aubry et al

United European Gastroenterol J. 2017, vol 5(2): 261–269

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349360/

■ Irritable bowel syndrome: clinical manifestations, dietary influences and management

Ronald Ikechi, Bradford D. Fischer, Joshua DeSipio, Sangita Phadtare

Healthcare (Basel) 2017, vol 5(2): 21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492024/

■ Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients

Anamaria Cozma-Petruţ, Felicia Loghin, Doina Miere, Dan Lucian Dumitraşcu

World J Gastroenterol. 2017, vol 23(21): 3771–378

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467063/

■ Dietary fiber in irritable bowel syndrome (review)

Magdy El-Salhy, Synne Otterasen Ystad, Tarek Mazzawi, Doris Gundersen

Int J Mol Med. 2017, vol 40(3): 607–613

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548066/

■ Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort

Camille Buscail, Jean-Marc Sabate, Michel Bouchoucha, Marion J. Torres, Benjamin Allès, Serge Hercberg, Robert Benamouzig, Chantal Julia

PLoS One. 2017; vol 12(8): e0183039

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571937/

■ Irritable bowel syndrome and diet

Piero Portincasa, Leonilde Bonfrate, Ornella de Bari et al

Gastroenterol Rep (Oxf) 2017, vol 5(1): 11–1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444258/

■ Dietary triggers in irritable bowel syndrome: Is there a role for glúten?

Umberto Volta, Maria Ines Pinto-Sanchez, Elisa Boschetti,et al

J Neurogastroenterol Motil. 2016 Oct; 22(4): 547–557

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056565/

■ The combination of oligo-and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: results of a randomized, placebo-controlled, double-blind, parallel group, multicentre clinical trial

Octavian Alexea, Vlad Bacarea, Núria Piqué

United European Gastroenterol J. 2016 Jun; 4(3): 455–465

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924437/

■ Comparison of symptoms, healthcare utilization, and treatment in diagnosed and undiagnoses individuals with diarrhea-predominant irritable bowel syndrome

Gregory S Sayuk, Ray Wolf, Lin Chang

Am J Gastroenterol. 2017,vol 112(6): 892–89

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465427/

■ Cognitive-behavioral therapy for patients with irritable bowel syndrome: currents insights

Sarah W Kinsinger

Psychol Res Behav Manag. 2017; vol 10: 231–237.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530860/

■ Psychological interventions for irritable bowel syndrome and inflammatory bowel disease

Sarah Ballou, Laurie Keefer

Clin Transl Gastroenterol. 2017 , vol 8(1): e214

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288603/

■ Sympton burden and consulting behavior in patients with overlapping functional disorders in the US population

Nimish Vakil, Margie Stelwagon, Elizabeth P Shea, Steve Miller

United European Gastroenterol J. 2016 Jun; 4(3): 413–422

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924424/

■ Systematic review: the placebo effect of psychological interventions in the treatment of irritable bowel syndrome

Carla E Flik, Laura Bakker, Wijnand Laan, Yanda R van Rood, André J P M Smout, Niek J de Wit

World J Gastroenterol. 2017, vol 23(12): 2223–2233

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374135/

■ Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea

Jessica L. Buono, Robyn T. Carson, Natalia M. Flores

Health Qual Life Outcomes. 2017; vol 15: 35

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310011/

■ High risk of temperomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?

Serena Gallotta, Vincenzo Bruno, Santo Catapano, et al

World J Gastroenterol. 2017 Jan 7; 23(1): 103–109

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221272/

■ Acupuncture for irritable bowel syndrome: 2-year follow-up of a randomized controlled trial

H MacPherson, H Tilbrook, D Agbedjro et al

Acupunct Med. 2017, vol 35(1): 17–23

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466911/

■ Targeting histamine receptors in irritable bowel syndrome: a critical appraisal

Adam Fabisiak, Jakub Włodarczyk, Natalia Fabisiak et AL

J Neurogastroenterol Motil. 2017 Jul; 23(3): 341–348

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503283/

■ Neuroendocrine dysregulation in irritable bowel syndrome patients: a pilot study

Cristina Stasi, Massimo Bellini, Dario Gambaccini, et AL

J Neurogastroenterol Motil. 2017 Jul; 23(3): 428–434

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503293/

■ Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant irritable bowel syndrome: a parallel-group trial

Aelee Jang, Sun-Kyung Hwang, Nikhil S Padhye, Janet C Meininger

J Neurogastroenterol Motil. 2017 Jul; 23(3): 435–445

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503294/

■ Maturation phenotype of peripheral blood monocyte/macrophage after stimulation with lipopolysaccharides in irritable bowel syndrome

riggers in irritable bowel syndrome: Is ther a role for gluten?

Oscar A Rodríguez-Fandiño, Joselín Hernández-Ruiz, Yolanda López-Vidal et al

J Neurogastroenterol Motil. 2017 Apr; 23(2): 281–288

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383123/

■ Balance of autonomic nervous system predicts who benefits from a self-management intervention program for irritable bowel syndrome

Monica E Jarrett, Kevin C Cain, Pamela G Barney et al

J Neurogastroenterol Motil. 2016 Jan; 22(1): 102–11

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699727/

■ Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104: H4: a cohort study with prospective follow-up

Viola Andresen, Bernd Löwe, Wiebke Broicher et al

United European Gastroenterol J. 2016 Feb; 4(1): 121–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766540/

■ Visceral pain perception in patients with irritable syndrome and healthy volunteers is affected by the MRI scanner environment

Reuben K Wong, Lukas Van Oudenhove, Xinhua Li,et al

United European Gastroenterol J. 2016 Feb; 4(1): 132–141

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766539/

■ Update on irritable bowel syndrome diagnostics and therapeutics

Mark Pimentel

Gastroenterol Hepatol (N Y) 2016 Jul; 12(7): 442–445.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969781/

■ Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage

Evangelos J. Giamarellos-Bourboulis, Emmanouel Pyleris, Charalambos Barbatzas, Aikaterini Pistiki, Mark Pimentel

BMC Gastroenterol. 2016; 16: 67

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940948/

■ Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowe syndrome in a clinical study population

Leticia Delgado-Herrera, Kathryn Lasch, Bernhardt Zeiher et al

Therap Adv Gastroenterol. 2017 , vol 10(9): 673–68

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598814/

■ Cytokine and anti-cytokine therapies in preventionor treatment in fibrosis in IBD

Noam Jacob, Stephan R Targan, David Q Shih

United European Gastroenterol J. 2016 Aug; 4(4): 531–540

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971798/

■ Parasitosis y síndrome de intestino irritable.

Ibarra, Catalina et al.

Rev. chil. infectol., Jun 2016, vol.33, no.3, p.268-274

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182016000300003&lng=en&nrm=iso

■ Irritable bowel syndrome subtypes: clinical and psychological features, body mass index and comorbidities

Kibune-Nagasako, Cristiane et al.

Rev. esp. enferm. dig., Feb 2016, vol.108, no.2, p.59-64

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016000200002&lng=en&nrm=iso

■ Irritable bowel syndrome: modern concepts and management options

G S Sayuk, C Prakash Gyawali

Am J Medicine 2015, vol 128 (8): 817-827

http://www.amjmed.com/article/S0002-9343(15)00168-0/fulltext

■ Diagnosis and management of IBS in adults

T Wilkins, C Pepitone, B Alex, R R Schade

Am Fam Physician 2012, vol 86 (5): 419-426

http://www.aafp.org/afp/2012/0901/p419.html

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

CRMMG: 7026

Email: pfleite1873@gmail.com

Hepatopatia Alcoólica Online (Alcoholic liver disease)

Por Paulo Leite 27/09/2017

■ Emerging concepts in alcoholic hepatitis

Phoenix Fung, Nikolaos Pyrsopoulos

World J Hepatol. 2017 Apr 28; 9(12): 567–585

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411952/

■ Pathophysiology and management of alcoholic liver disease – update 2016

Felix Stickel, Christian Datz, Jochen Hampe, Ramon Bataller

Gut Liver. 2017, vol 11(2): 173–188

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347641/

■ Alcoholic liver disease: pathogenesis and current management

Natalia A. Osna, Terrence M. Donohue, Jr., Kusum K. Kharbanda

Alcohol Res. 2017; vol 38(2): 147–161

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513682/

■ Current management of alcoholic hepatitis and future therapies

Behnam Saberi, Alia S. Dadabhai, Yoon-Young Jang et al

J Clin Transl Hepatol. 2016 Jun 28; 4(2): 113–122

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913072/

■ Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations

R Parker, S Kim, B Gao

Nature Reviews Gastroenterology & Hepatology sep 2017

https://www.nature.com/nrgastro/journal/vaop/ncurrent/full/nrgastro.2017.116.html

■ Follow-up of alcohol consumption after liver transplantation: Interest of na addiction team?

H Donnadieu-Rigole, L Olive, B Nalpas et AL

Alcoholism 2017, vol 41 (1): 165-170

http://onlinelibrary.wiley.com/doi/10.1111/acer.13276/full

■ Infections in severe alcoholic hepatitis

Eleni Karakike, Christophe Moreno, Thierry Gustot

Ann Gastroenterol. 2017; 30(2): 152–160

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320027/

■ Treatment of alcoholic liver disease

Timothy R. Morgan

Gastroenterol Hepatol (N Y) 2017 Jul; 13(7): 425–427.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572973/

■ Alcoholic liver disease

Lauren A. Beste

Gastroenterol Hepatol (N Y) 2016 Jan; 12(1): 48–50.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865786/

■ Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis

Maria Kalafateli, Christos Triantos, Emmanuel Tsochatzis et al

World J Gastroenterol. 2015 Mar 14; 21(10): 3020–3029

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356923/

■ Advances in alcoholic liver disease: an update on alcoholic hepatitis

R Liang, A Liu, R B Permpail et AL

World J Gastroenterol 2015, vol 21 (42): 11893-11903

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641111/

■ Alcohol policies and alcoholic cirrhosis mortality in the United States

Scott E. Hadland, Ziming Xuan, Jason G. Blanchette, Timothy C. Heeren, Monica H. Swahn, Timothy S. Naimi

Prev Chronic Dis. 2015; 12: E177

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611859/

■ Non-invasive diagnosis of alcoholic liver disease

Sebastian Mueller, Helmut Karl Seitz, Vanessa Rausch

World J Gastroenterol. 2014 Oct 28; 20(40): 14626–14641

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209529/

■ Therapy for alcoholic liver disease

Maryconi M Jaurigue, Mitchell S Cappell

World J Gastroenterol. 2014 Mar 7; 20(9): 2143–2158

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942819/

■ Alcoholic and non-alcoholic steatohepatitis

Manuela G. Neuman, Samuel W. French, Barbara A. French et al

Exp Mol Pathol. 2014 Dec; 97(3): 492–510

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696068/

■ Hepatite alcoólica aguda – artigo de revisão

L Matos, P Batista, N Monteiro et al

GE J Port Gastroenterol 2013, vol 20 (4): 153-161

http://www.scielo.mec.pt/pdf/ge/v20n4/v20n4a04.pdf

■ Liver transplantation for alcoholic liver disease among Canadian transplant centres: a national study

N Chandok, M Aljawad, A White et al

Can J Gastroenterol 2013, vol 27 (11): 643-646

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816946/

■ Nutrição em paciente cirrótico

F J Martins

HU Revista 2013, vol 39 (3-4)

http://docs.bvsalud.org/biblioref/2016/09/1917/2228-12868-1-pb.pdf

■ The utility of scoring system in predicting early and late mortality in alcoholic hepatitis: Whose score is it anywayS D Ryder, P Kaye, G P Aithal

International Journal of Hepatology 2012 (2012), Article ID 5624675, 5 pages

https://www.hindawi.com/journals/ijh/2012/624675/

■ Álcool e o Fígado

M Mincis, R Mincis

GED gastroenterol.endosc.dig 2011, vol 30 (4): 152-162

http://files.bvs.br/upload/S/0101-7772/2011/v30n4/a3598.pdf

■ Treatment of decompensated alcoholic liver disease

John Menachery, Ajay Duseja

Int J Hepatol. 2011; 2011: 219238

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170741/

■ Alcoholic hepatitis 2010: a clinician´s guide to diagnosis and therapy

M Amini, B R Runyon